Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

President, Greater China

President

Global General Counsel

Chief Executive Officer

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Viatris Inc. operates as a healthcare company worldwide.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-13	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-05	Premium	sold	Premium	Premium	Premium	See Remarks
2024-03-05	Premium	sold	Premium	Premium	Premium	-
2024-03-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	acquired	Premium	Premium	Premium	President, Greater China
2024-03-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	President
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold	Premium	Premium	Premium	President, Greater China
2024-03-04	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-04	Premium	sold (taxes)	Premium	Premium	Premium	Global General Counsel
2024-03-04	Premium	acquired	Premium	Premium	Premium	Global General Counsel
2024-03-04	Premium	acquired	Premium	Premium	Premium	President
2024-03-03	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-03	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-03-03	Premium	acquired	Premium	Premium	Premium	-
2024-03-03	Premium	sold (taxes)	Premium	Premium	Premium	President
2024-03-03	Premium	acquired	Premium	Premium	Premium	President
2024-03-03	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-03-03	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-03-03	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2024-03-03	Premium	acquired	Premium	Premium	Premium	-
2024-03-03	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks

VTRS - Viatris Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for VTRS